Global Small Animal Vivo Imaging Market
Marktgröße in Milliarden USD
CAGR :
% 
 Prognosezeitraum |
2024 –2031 |
 Marktgröße (Basisjahr) | USD 1.06 Million |
 Marktgröße (Prognosejahr) | USD 1.98 Million |
 CAGR |
% |
| Wichtige Marktteilnehmer |
|
Global Small Animal (In-Vivo) Imaging Market Segmentation, By Modality (Optical Imaging Systems, Nuclear Imaging Systems, Micro-MRI, Micro-Ultrasound, Micro-CT, Photoacoustic Imaging Systems, Magnetic Particle Imaging Systems), Reagents (Optical Imaging Reagents, Nuclear Imaging Reagents, MRI Contrast Agents, Ultrasound Contrast Agents, CT Contrast Agents), Application (Monitoring Drug treatment response, Bio distribution Studies, Cancer cell Detection, Biomarkers, Longitudinal Studies, Epigenetics) – Industry Trends and Forecast to 2031.
Small Animal (In-Vivo) Imaging Market Analysis
Small animal (in-vivo) imaging market is estimated to increase rapidly over the forecast period. Small animal imaging operations employ a variety of in-vivo techniques. These techniques are gaining traction and are being used to define mechanisms of action, target receptors, and conduct epigenetic research. The development and usage of multimodal instruments has grown rapidly in recent years, both in the preclinical and clinical stages of research. Dual-modality or hybrid PET/CT scanners are recommended; nevertheless, SPECT/CT scanners are already commonly utilized for regular analysis.
Small Animal (In-Vivo) Imaging Market Size
Global small animal (In-Vivo) imaging market size was valued at USD 1.06 billion in 2023 and is projected to reach USD 1.98 billion by 2031, with a CAGR of 8.1% during the forecast period of 2024 to 2031.
Report Scope and Market Segmentation
|
Attributes |
Small Animal (In-Vivo) Imaging Key Market Insights |
|
Segmentation |
|
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America. |
|
Key Market Players |
Bruker (U.S.), General Electric (U.S.), Koninklijke Philips N.V. (Netherlands), Hitachi Ltd. (Japan), Siemens Healthcare GmbH (Germany), FUJIFILM Corporation (Japan), PerkinElmer Inc. (U.S.), Miltenyi Biotec (Germany), CMR Naviscan (U.S.), SCANCO Medical AG (Switzerland), Aspect Imaging Ltd. (Israel), Mediso Ltd. (V.A.), LI-COR, Inc. (USA), Takara Bio Inc. (Japan), MILabs B.V. (Netherlands), M.R. Solutions (U.K.), Trifoil Imaging (U.S.), New England Biolabs (U.S.), Biospace Lab (France), Guerbet (France), Agilent Technologies, Inc.(U.S.), Thermo Fisher Scientific Inc. (U.S.) |
|
Market Opportunities |
|
Small Animal (In-Vivo) Imaging Market Definition
Small animal imaging (in-vivo) devices are a new type of diagnostic tool that may be used to diagnose a wide range of diseases in laboratory animals. Cancer cell research, monitoring drug response during drug development, examining the bio-distribution patterns of new chemical entities, biomarker research in animal models, longitudinal studies, and other disciplines all use a variety of small animal imaging (in-vivo) technologies. These devices have grown in popularity, and they are mostly employed in epigenetic research, receptor targeting, and determining the mechanism of action.
Small Animal (In-Vivo) Imaging Market Dynamics
Drivers
Over the projected period, rising use of multimodal imaging instruments expected to increase the market. Moreover, the rising expenditure for the healthcare sector will enhance the small animal (in-vivo) imaging market growth.
Furthermore, increasing adoption of non-invasive technology for small animal imaging projected to propel the market forward. Along with this, increasing urbanization and rising level of disposable income are the driving factors accelerating the growth of the small animal (in-vivo) imaging market. Also, increasing expenditure on healthcare infrastructure are the major market drivers that will further escalate the growth of small animal (in-vivo) imaging market. Small animal imaging systems and reagents have a wide range of uses in oncology, especially with the rise in cancer incidence around the world. The rising frequency of cardiovascular disorders is likely to boost the global small animal imaging market's growth in the cardiology application area.
Opportunities
- Increase in Pharmaceutical Industry and R&D Expenditure
An increase in pharmaceutical industry and R&D expenditure will provide beneficial opportunities for the small animal (in-vivo) imaging market growth. The creation and usage of multimodal imaging devices has seen remarkable expansion in the ongoing evolution of imaging technology. Pharmaceutical businesses' increased R&D spending is a direct result of changing industry structure, particularly the rise of the biotechnology section.
Moreover, growing focus of manufacturers on the adoption of advanced technologies in field of healthcare and increase in the number of emerging markets will further provide beneficial opportunities for the small animal (in-vivo) imaging market growth during the forecast period.
Restraints/Challenges
- Strict Regulations
The presence of strict regulations will impede the market’s growth rate during the forecast period. One of the greatest impediments to the small animal imaging business is strict regulation. Distinct countries' regulatory agencies have different sets of rules for the application of medical devices, leaving product makers in an unclear situation.
On the other hand, low healthcare expenditure in developing countries and the lack of common standards will challenge the small animal (in-vivo) imaging market. Additionally, the lack of skilled professionals and low awareness will restrain and further impede the growth rate of the market during the forecast period of 2024-2031.
This small animal (in-vivo) imaging market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the small animal (in-vivo) imaging market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Small Animal (In-Vivo) Imaging Market
The COVID-19 outbreak boosted the market for small animal (in-vivo) imaging. The majority of patients infected with COVID-19 have mild to moderate symptoms and recover at home, but some demanded medical intervention. COVID-19 appears to have a significant impact on the market.
In order to contain the COVID-19 spread, numerous governments enforced transit and travel restrictions, causing international trade and transportation to be hampered. As a result, the supply chain for small animal (in-vivo) imaging was interrupted, resulting in a temporary decrease in product demand. The market operators' capacity to offer small animal (in-vivo) imaging devices and apply previously sold products has been hampered by limited access to present and potential clients, resulting in a modest reduction in the growth rate in 2020. However, the supply chain disruption is projected to be mitigated in 2021, and the market is expected to develop at a faster rate during the projection period.
Small Animal (In-Vivo) Imaging Market Scope
The small animal (in-vivo) imaging market is segmented on the basis of modality, reagents, and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Modality
- Optical Imaging Systems
- Nuclear Imaging Systems
- Micro-MRI
- Micro-Ultrasound
- Micro-CT
- Photoacoustic Imaging Systems
- Magnetic Particle Imaging Systems
Reagents
- Optical Imaging Reagents
- Nuclear Imaging Reagents
- MRI Contrast Agents
- Ultrasound Contrast Agents
- CT Contrast Agents
Application
- Monitoring Drug treatment response
- Bio distribution Studies
- Cancer cell Detection
- Biomarkers
- Longitudinal Studies
- Epigenetics
Small Animal (In-Vivo) Imaging Market Regional Analysis
The small animal (in-vivo) imaging market is analyzed and market size insights and trends are provided by country, modality, reagents, and application as referenced above.
The countries covered in the small animal (in-vivo) imaging market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the small animal (in-vivo) imaging market because of the innovative modality innovations resulting from technological advancements in this region.
Europe is expected to grow during the forecast period due to the presence of large number of diagnostic device manufacturers in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Small Animal (In-Vivo) Imaging Market Share
The Small animal (in-vivo) imaging market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to small animal (in-vivo) imaging market.
Small Animal (In-Vivo) Imaging Market Leaders Operating in the Market Are:
- Bruker (U.S.)
- General Electric (U.S.)
- Koninklijke Philips N.V. (Netherlands)
- Hitachi Ltd. (Japan)
- Siemens Healthcare GmbH (Germany)
- FUJIFILM Corporation (Japan)
- Bruker (U.S.)
- PerkinElmer Inc (U.S.)
- Miltenyi Biotec (Germany)
- CMR Naviscan (U.S.)
- SCANCO Medical AG (Switzerland)
- Aspect Imaging Ltd (Israel)
- Mediso Ltd (V.A.)
- LI-COR, Inc (USA)
- Takara Bio Inc (Japan)
- MILabs B.V. (Netherlands)
- M.R. Solutions (U.K.)
- Trifoil Imaging (U.S.)
- New England Biolabs (U.S.)
- Biospace Lab (France)
- Guerbet (France)
- Agilent Technologies, Inc (U.S.)
- Thermo Fisher Scientific Inc (U.S.)
SKU-
Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud
- Interaktives Datenanalyse-Dashboard
- Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
- Zugriff für Research-Analysten für Anpassungen und Abfragen
- Konkurrenzanalyse mit interaktivem Dashboard
- Aktuelle Nachrichten, Updates und Trendanalyse
- Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Forschungsmethodik
Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.
Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.
Anpassung möglich
Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.
